Zuranolone for the Treatment of Postpartum Depression
149 Citations•2023•
Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Bassem Maximos
Zuranolone demonstrated significant improvements in depressive symptoms and was generally well tolerated, supporting the potential of zuranol one as a novel, rapid-acting oral treatment for PPD.
Abstract
In this trial, zuranolone demonstrated significant improvements in depressive symptoms and was generally well tolerated, supporting the potential of zuranolone as a novel, rapid-acting oral treatment for PPD.